We separated the expression data matrix in the TCGA-BLCA dataset into BHLHE41high and BHLHE41low groups based on the median expression level of BHLHE41 and then performed bioinformatic analysis to evaluate the potential mechanisms of tumor inhibition mediated by BHLHE41. This evidence concerns the gene BHLHE41 and bladder transitional cell carcinoma.